Skip to main content
    K

    Korro Bio, Inc. (KRRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $12.71
    -0.90 (-6.61%)

    Market Cap: $186.81M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Korro Bio, Inc. (KRRO) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Korro Bio (KRRO) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Korro Bio reported EPS of -$0.98, above the -$1.14 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(17/29)
    Avg Surprise
    -71.63%
    Streak
    5 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.38
    Range-$2.39 - -$0.62
    14 analysts
    Revenue Consensus
    $2.19M
    RangeN/A
    12 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.03
    Range-$1.25 - -$0.80
    6 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.04+1.5%
    60d ago-$1.04+1.5%
    30d ago-$1.04+1.5%
    7d ago-$1.04+1.5%
    Current-$1.03
    Revenue Consensus
    $125.00K
    RangeN/A
    4 analysts

    Next Report

    KRRO has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 29 quarters below that had an estimate, KRRO beat 17, missed 10 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 986.86% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.98-$1.14-$2.04 - -$0.93+14.04%BeatN/A100 up, 1 downNov 5, 2026N/A
    Jun 30, 2026-$1.07-$1.54-$2.10 - -$0.66+30.52%BeatN/A93 up, 2 downAug 6, 2026N/A
    Mar 31, 2026-$1.69-$1.98-$3.41 - -$1.31+14.73%BeatN/A53 up, 0 downMay 7, 2026N/A
    Dec 31, 2025-$1.65-$2.14-$3.19 - -$1.44+22.90%BeatN/A81 up, 0 downMar 12, 2026$1.29M
    Sep 30, 2025-$1.92-$2.68-$3.51 - -$2.40+28.36%BeatN/A82 up, 6 downNov 12, 2025$1.09M
    Jun 30, 2025-$2.74-$2.59-$3.41 - -$2.07-5.79%MissN/A9N/AAug 12, 2025$1.46M
    Mar 31, 2025-$2.49-$2.62-$3.14 - -$2.30+4.96%BeatN/A81 up, 4 downMay 7, 2025$2.55M
    Dec 31, 2024-$2.26-$2.51-$2.90 - -$2.00+10.06%BeatN/A7N/AMar 18, 2025$2.27M
    Sep 30, 2024-$2.26-$2.53-$2.84 - -$2.40+10.67%BeatN/A50 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$2.43-$2.43N/A0.00%In lineN/AN/AN/AAug 13, 2024N/A
    Mar 31, 2024-$2.44-$2.49-$2.54 - -$2.23+2.01%BeatN/A30 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$25.65-$2.36-$2.95 - -$1.99-986.86%MissN/A30 up, 0 downMar 29, 2024N/A
    Sep 30, 2023-$15.50-$17.73N/A+12.58%BeatN/AN/AN/ANov 2, 2023N/A
    Jun 30, 2023-$0.30-$0.36N/A+16.67%BeatN/AN/AN/AAug 10, 2023N/A
    Mar 31, 2023-$0.55-$0.42N/A-30.95%MissN/AN/AN/AMay 12, 2023N/A
    Dec 31, 2022-$0.49-$0.63N/A+22.35%BeatN/AN/AN/AMar 10, 2023N/A
    Sep 30, 2022-$0.55-$0.57N/A+3.51%BeatN/AN/AN/ADec 29, 2022N/A
    Jun 30, 2022-$0.61-$0.66N/A+8.04%BeatN/AN/AN/ASep 28, 2022N/A
    Mar 31, 2022-$0.67-$0.64N/A-5.36%MissN/AN/AN/AJun 29, 2022N/A
    Dec 31, 2021-$0.62$0.15N/A-506.02%MissN/AN/AN/AMar 30, 2022N/A
    Sep 30, 2021-$0.73-$0.59N/A-23.94%MissN/AN/AN/ADec 29, 2021N/A
    Jun 30, 2021-$0.52-$0.51N/A-2.24%MissN/AN/AN/ASep 28, 2021$9.42M
    Mar 31, 2021-$0.60$0.14N/A-536.36%MissN/AN/AN/AJun 28, 2021$4.65M
    Dec 31, 2020-$0.30-$0.25N/A-18.11%MissN/AN/AN/AMar 30, 2021$9.95M
    Sep 30, 2020-$0.16-$0.28N/A+42.34%BeatN/AN/AN/ANov 16, 2020$11.25M
    Jun 30, 2020-$0.19-$0.19N/A0.00%In lineN/AN/AN/AAug 12, 2020$8.52M
    Mar 31, 2020-$0.16-$0.17N/A+5.88%BeatN/AN/AN/AJun 29, 2020$7.26M
    Dec 31, 2019-$0.19$0.10N/A-290.00%MissN/AN/AN/AMar 30, 2020$4.71M
    Sep 30, 2019-$0.73-$3.42N/A+78.66%BeatN/AN/AN/ANov 18, 2019$24.24M
    Jun 30, 2019-$0.28N/AN/AN/AN/AN/AN/AN/ASep 23, 2019N/A
    Last 30 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$8.80, after -$9.39 the year before. It was -$1.20 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$8.80N/A
    Dec 31, 2024-$9.39N/A
    Dec 31, 2023-$42.00N/A
    Dec 31, 2022-$2.32N/A
    Dec 31, 2021-$2.47N/A
    Dec 31, 2020-$0.81N/A
    Dec 31, 2019-$1.20N/A

    Frequently Asked Questions About KRRO

    When is Korro Bio's next earnings date?

    Korro Bio's next earnings report is expected for Mar 10, 2027.

    Did KRRO beat earnings estimates last quarter?

    Yes. Korro Bio reported EPS of -$0.98 for the quarter ended Sep 30, 2026, above the -$1.14 estimate, a 14.04% surprise.

    What EPS do analysts expect from KRRO next quarter?

    The consensus EPS estimate for Korro Bio for the quarter ending Dec 31, 2026 is -$1.38 from 14 analysts, with estimates from -$2.39 to -$0.62.

    How often does KRRO beat earnings estimates?

    Korro Bio beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +14.97%.